Video Library
Progression of an acute clot to CTEPH
Learn more about the stages of progression of an acute clot to CTEPH, sometimes mistakenly referred to as "chronic clot" or "chronic PE.”
CTEPH Pathophysiology
Victor F. Tapson, MD, of Cedars-Sinai Medical Center, Los Angeles, looks at how CTEPH develops, how it manifests, and important considerations in distinguishing CTEPH from PAH.
Differential diagnosis of CTEPH
Raymond L. Benza, MD, of Allegheny General Hospital, Pittsburgh, works through the differential diagnosis of CTEPH, outlining diagnostic difficulties and a helpful mnemonic device for clinicians.
V/Q Scanning and RHC
William R. Auger, MD, of Temple University Hospital, discusses the use of V/Q scanning and right heart catheterization in CTEPH.
Potential precursors to CTEPH
Paul Forfia, MD, of Temple University Hospital, Philadelphia, discusses how venous thromboembolism can be a potential precursor to CTEPH.
PTE/PEA Surgery
Richard Channick, MD, of UCLA Medical Center reviews pulmonary thromboendarterectomy (PTE or PEA), the only potentially curative treatment for CTEPH.
V/Q scan and CTPA
Raymond L. Benza, MD, of Allegheny Health Network, Pittsburgh, reviews the respective roles of ventilation/perfusion scans and computed tomographic pulmonary angiography in CTEPH.
Key steps in PTE surgery
Michael Madani, MD. FACS of the PTE Program at UCSD, performing PTE/PEA surgery, including extraction of thromboembolic material.
Operability assessment in CTEPH
Bill Auger, MD of the PTE Program at Temple University Hospital reviews important considerations in evaluating patient eligibility for potentially curative PTE/PEA surgery.
Reassessing a misdiagnosis
Ivan Robbins, MD, of Vanderbilt University Medical Center, Nashville, presents a case illustrating the importance of the ventilation/perfusion scan as a screen for CTEPH.
BAYER and the Bayer Cross are registered trademarks of Bayer. All other trademarks are property of their respective owners. These trademark owners are not affiliated with Bayer and do not sponsor or endorse Bayer.
Site last modified 03/2021
© 2021 Bayer. All rights reserved.
